Glucocorticoids Induce Rapid Up-Regulation of Mitogen-Activated Protein Kinase Phosphatase-1 and Dephosphorylation of Extracellular Signal-Regulated Kinase and Impair Proliferation in Human and Mouse Osteoblast Cell Lines
Open Access
- 1 February 2003
- journal article
- other
- Published by The Endocrine Society in Endocrinology
- Vol. 144 (2) , 412-422
Abstract
A central feature of glucocorticoid (GC)-induced osteoporosis is decreased bone formation, secondary to decreased numbers of functional osteoblasts. We find that ERK activity is essential for serum-induced osteoblast proliferation in vitro because inhibition of MAPK/ERK kinase activity by U0126 completely abolished both serum-induced activation of ERK and proliferation of mouse (MBA-15.4) and human (MG-63) osteoblast cell lines. Dexamethasone (Dex) rapidly (<2 h) inhibits the sustained phase of ERK activation, required for nuclear shift and mitogenesis. This inhibition is reversed by cotreatment with the protein synthesis inhibitor, cycloheximide, and by the GC receptor antagonist, RU486, suggesting a classical transcriptional mechanism. Phosphatase activity was up-regulated by Dex treatment, and inhibition of ERK activity by Dex was also reversed by the protein tyrosine phosphatase inhibitor, vanadate. Coupled with the rapidity of Dex action, this indicates immediate-early gene phosphatase involvement, and we therefore used quantitative, real-time PCR to examine expression profiles of the dual-specificity MAPK phosphatases, MKP-1 and MKP-3. MKP-1, but not MKP-3, mRNA expression was 10-fold up-regulated in both mouse and human osteoblast cell lines within 30 min of Dex treatment and remained elevated for 24 h. MKP-1 protein was also markedly up-regulated following 1–8 h of Dex treatment, and this correlated precisely with dephosphorylation of ERK. Cell proliferation was impaired by Dex treatment, and this was reversed by both RU486 and vanadate. Therefore, MKP-1 up-regulation provides a novel and rapid mechanism, whereby GCs inhibit osteoblast proliferation.Keywords
This publication has 49 references indexed in Scilit:
- Epsins and Vps27p/Hrs contain ubiquitin-binding domains that function in receptor endocytosisNature Cell Biology, 2002
- Map Kinase Phosphatases (MKP's) Are Early Responsive Genes during Induction of Cerulein Hyperstimulation PancreatitisBiochemical and Biophysical Research Communications, 2000
- Map kinase phosphatases (MKPS) are early responsive genes during induction of cerulein hyperstimulation pancreatitisGastroenterology, 2000
- Protein Tyrosine Kinase Inhibitors Block the Stimulatory Actions of Phosphotyrosine Phosphatase Inhibitors to Increase Cell Proliferation, Alkaline Phosphatase Activity, and Collagen Synthesis in Normal HumanBone CellsAmerican Journal of Nephrology, 2000
- Involvement of ERK in BMP-2 Induced Osteoblastic Differentiation of Mesenchymal Progenitor Cell Line C3H10T1/2Biochemical and Biophysical Research Communications, 2000
- A Phosphotyrosyl Mimetic Peptide Reverses Impairment of Insulin-Stimulated Translocation of GLUT4 Caused by Overexpression of PTP1B in Rat Adipose CellsBiochemistry, 1998
- Cell cycle targets of Ras/Raf signallingOncogene, 1998
- Activation of Extracellular Signal-Regulated Kinases 1 and 2 (ERK1 and ERK2) by FGF-2 and PDGF-BB in Normal Human Osteoblastic and Bone Marrow Stromal Cells: Differences in Mobility and In-Gel Renaturation of ERK1 in Human, Rat, and Mouse Osteoblastic CellsBiochemical and Biophysical Research Communications, 1997
- Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγScience, 1996
- Progesterone and dexamethasone inhibition of uterine epithelial cell proliferation: Studies with antiprogesterone compounds in the neonatal mouseThe Journal of Steroid Biochemistry and Molecular Biology, 1993